The integrin heterodimer CD11b/CD18 (?M?2, Mac-1,
CR3) expressed on monocytes or polymorphonuclear
leukocytes (PMN) is a receptor for iC3b, fibrinogen,
heparin, and for intercellular adhesion molecule
(ICAM)-1 on endothelium, crucially contributing to
vascular cell interactions in inflammation and atherosclerosis.
In this report, we summarize our findings on
the effects of lipid mediators and lipid-lowering drugs.
Exposure of endothelial cells to oxidized low density
lipoprotein (oxLDL) induces upregulation of ICAM-1
and increases adhesion of monocytic cells expressing
Mac-1. Inhibition experiments show that monocytes
use distinct ligands, i.e. ICAM-1 and heparan sulfate
proteoglycans for adhesion to oxLDL-treated endothelium.
An albumin-transferable oxLDL activity is inhibited
by the antioxidant pyrrolidine dithiocarbamate
(PDTC), while 8-epi-prostaglandin F2? (8-epi-PGF2?)
or lysophosphatidylcholine had no effect, implicating
yet unidentified radicals. Sequential adhesive and signaling
events lead to the firm adhesion of rolling PMN
on activated and adherent platelets, which may occupy
areas of endothelial denudation. Shear-resistant
arrest of PMN on thrombin-stimulated platelets in
flow conditions requires distinct regions of Mac-1, involving
its interactions with fibrinogen bound to platelet
?llb?3, and with other platelet ligands. Both arrest
and adhesion strengthening under flow are stimulated
by platelet-activating factor and leukotriene B4, but
not by the chemokine receptor CXCR2. We tested
whether Mac-1-dependent monocyte adhesiveness is
affected by inhibitors of hydroxy-methylglutaryl-Coenzyme
A reductase (statins) which improve morbidity
and survival of patients with coronary heart disease.
As compared to controls, adhesion of isolated
monocytes to endothelium
Print ISSN: 1434-6621
Volume: 37, 03/1999
Pages: 243 - 254